Pfizer's Braftovi combo on track for full approval in win for FDA's Project FrontRunner
What Trump’s second term could mean for PDUFA’s future
Sionna eyes up $156M IPO to fund cystic fibrosis trials
Thermo Fisher's layoff spree continues with 300 cuts in Massachusetts
*please scroll down for all the latest news*
